Characterization of factor IX defects in hemophilia B patients.
Thompson
A R
AR
Department of Medicine, University of Washington, Seattle 98104.
Chen
S H
SH
D000595:Amino Acid Sequence; D016375:Antisense Elements (Genetics); D001483:Base Sequence; D001777:Blood Coagulation; D015139:Blotting, Southern / Q000379:methods; D003062:Codon / Q000235:genetics; D004247:DNA / Q000032:analysis; D017931:DNA Primers; D004587:Electrophoresis, Agar Gel / Q000379:methods; D005091:Exons; D005164:Factor IX / Q000032:analysis / Q000235:genetics* / Q000378:metabolism*; D002836:Hemophilia B / Q000097:blood* / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D007202:Indicators and Reagents; D007438:Introns; D008969:Molecular Sequence Data; D010761:Phosphorus Radioisotopes; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D011863:Radioimmunoassay / Q000379:methods; D015183:Restriction Mapping; D013462:Sulfur Radioisotopes
D016375:Antisense Elements (Genetics); D003062:Codon; D017931:DNA Primers; D007202:Indicators and Reagents; D010761:Phosphorus Radioisotopes; D013462:Sulfur Radioisotopes; D005164:Factor IX; D004247:DNA